Genomics

Dataset Information

0

Bcl2-induced vascular maturation


ABSTRACT: Overexpression of a caspase-resistant form of Bcl-2 (D34A) in human umbilical vein endothelial cells (EC) implanted into immunodeficient mice promotes the maturation of human EC-lined microvessels invested by vascular smooth muscle cells (VSMC) of mouse origin. In contrast, EC implants not overexpressing Bcl-2 form only simple, uncoated EC tubes. Here we compare the phenotypes of vessels formed in vivo and the transcriptomes in vitro of EC expressing different forms of Bcl-2. Wild type Bcl-2, like the caspase resistant D34A Bcl-2 mutant, is anti-apoptotic in vitro and promotes VSMC recruitment in vivo, whereas a G145E mutant that has diminished anti-apoptotic activity in vitro does not promote vessel maturation in vivo. The D34A and wild type forms of Bcl-2, but not the G145E mutant form of Bcl-2 significantly regulate RNA transcripts previously associated with EC-VSMC interactions and VSMC biology, including matrix Gla protein, insulin like growth factor binding protein (IGFBP)-2, matrix metaloproteinase-14 (MMP14), ADAM17 and Stanniocalcin-1. These effects of Bcl-2 on the transcriptome are detected in EC cultured as angiogenic 3-D tubes but are attenuated in EC cultured as 2-D monolayers. Bcl-2-regulated transcription in EC may contribute to vascular maturation, and support design of tissue engineering strategies using EC. Keywords: genetic modification, growth condition modification.

ORGANISM(S): Homo sapiens

PROVIDER: GSE10710 | GEO | 2008/03/05

SECONDARY ACCESSION(S): PRJNA107589

REPOSITORIES: GEO

Similar Datasets

| E-GEOD-10710 | biostudies-arrayexpress
| E-GEOD-619 | biostudies-arrayexpress
| E-MTAB-966 | biostudies-arrayexpress
2003-10-28 | GSE615 | GEO
2022-06-04 | GSE199240 | GEO
2003-10-28 | GSE619 | GEO
2003-10-28 | GSE616 | GEO
2021-12-15 | GSE161179 | GEO
2017-03-01 | PXD005712 | Pride
2005-01-01 | MODEL1006230056 | BioModels